Medicaid Breast Cancer Access to Treatment Act

Overview: HR 4543, the Medicaid Breast Cancer Access to Treatment Act, was introduced in the House on July 17, 2025.

Purpose and Intent: The bill aims to improve access to breast cancer treatment for individuals enrolled in Medicaid. It seeks to ensure that Medicaid beneficiaries diagnosed with breast cancer can receive the necessary treatment without delay or interruption.

Key Provisions:
- Requires state Medicaid programs to provide coverage for breast cancer treatment, including chemotherapy, radiation therapy, and surgery.
- Prohibits state Medicaid programs from imposing any waiting periods or other restrictions that would delay the start of breast cancer treatment.
- Ensures that Medicaid beneficiaries can maintain their coverage and access to treatment for the duration of their cancer treatment.

Affected Parties and Impacts:
- The bill would directly benefit Medicaid beneficiaries diagnosed with breast cancer, providing them with timely access to comprehensive treatment.
- It could also have a positive impact on public health by improving breast cancer outcomes and reducing the burden on the healthcare system.

Procedural and Timeline Considerations:
The bill has been introduced in the House and is currently in the legislative process. The next steps would involve committee review, potential amendments, and a vote by the full House before it can move to the Senate.